Cargando…
Analysis of the Ex Vivo and In Vivo Antiretroviral Activity of Gemcitabine
Replication of retroviral and host genomes requires ribonucleotide reductase to convert rNTPs to dNTPs, which are then used as substrates for DNA synthesis. Inhibition of ribonucleotide reductase by hydroxyurea (HU) has been previously used to treat cancers as well as HIV. However, the use of HU as...
Autores principales: | Clouser, Christine L., Holtz, Colleen M., Mullett, Mary, Crankshaw, Duane L., Briggs, Jacquie E., Chauhan, Jay, VanHoutan, Ilze Matise, Patterson, Steven E., Mansky, Louis M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3021508/ https://www.ncbi.nlm.nih.gov/pubmed/21264291 http://dx.doi.org/10.1371/journal.pone.0015840 |
Ejemplares similares
-
Broadening the use of antiretroviral therapy: the case for feline leukemia virus
por: Greggs, Willie M, et al.
Publicado: (2011) -
Combination chemotherapy for choroidal melanoma: ex vivo sensitivity to treosulfan with gemcitabine or Cytosine arabinoside
por: Neale, M H, et al.
Publicado: (1999) -
Combination chemotherapy in advanced gastrointestinal cancers: ex vivo sensitivity to gemcitabine and mitomycin C
por: Whitehouse, P A, et al.
Publicado: (2003) -
An Orally Bioavailable (Mice) Prodrug of Glutathione
por: Crankshaw, Daune L., et al.
Publicado: (2021) -
Dexamethasone-induced cisplatin and gemcitabine resistance in lung carcinoma samples treated ex vivo
por: Gassler, N, et al.
Publicado: (2005)